XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.15

-0.7%

Jan 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (9302)	3/20/1999 9:01:00 PM
From: aknahow	Read Replies (2) of 17367

Cacaito, this must have disturbed you greatly because I now not that after teaching me to say arms, rather than legs, you now say legs. <g> Original accruals contemplated were 200. Placebo 80% in less severe. Mortality 20% = 16 Placebo 20% in more severe. Mortality 30% = 6 . ......... ......................... = 22 Treatment 80% in less severe. Deaths 10% = 8 20% in more severe Deaths 15% = 3 ......................................... = 11 Total assumed mortality at start of trial 33 Obviously many other conclusions could be reached. I have no knowledge of any facts that would permit an accurate calculation. I post in part because shareholders were deprived of crucial information in theory to keep them from speculating on the above. This was unfair and not something the DSMB should have done. The actions of the DSMB created greater uncertainty and did not help to strengthen XOMA financially. If there is a next time I hope XOMA will be stronger and not let a DSMB intrude into a this type of decision.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next